…line in composite MDADI scores after treatment at 2 years.58 At Memorial Sloan Kettering Cancer Center, a cohort of 276 HPV-positive OPC patients (including 31.5% AJC…
Memorial Sloan Kettering Cancer Center
This institution is selected. Its supporting articles are shown below.
Articles mentioning Memorial Sloan Kettering Cancer Center
9 articles · page 1 of 1…MPP, microns per pixel; MSI, microsatellite instability; MSKCC, Memorial Sloan Kettering Cancer Center; NKI, Netherlands Cancer Institute; PAIP, Pathology Artificial …
…This non-randomized, open-label, phase 2 study was conducted at Memorial Sloan Kettering Cancer Center. Patients with metastatic or unresectable DDLPS, or those expec…
… (HR=0.82, 95% CI 0.67 to 1.00, p=0.05). Notably, patients with Memorial Sloan Kettering Cancer Center poor risk demonstrated clear benefits from ICIs in this populat…
…lone) (n=2768) or chemoimmunotherapy (chemo-IO) (n=1389) at the Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center (2010–2023). Associa…
…T # 2023-505334-10-01) Institutional Review Board/Privacy Board/Memorial Sloan Kettering Cancer Center (23-239) CEIm HM Hospitales (CT # 2023-505334-10-01) WCG IRB (I…
…CT The James Cancer Center, Ohio State University, Columbus, OH Dana Farber Cancer Institute, Boston, MA, Columbia University Irving Medical Center, New Yor…
…ditor of this journal.Ethics Approval The study was approved by Memorial Sloan Kettering Cancer Center‘s Institutional Review Board. IRB# 19-461 Initial Approval Date…
…10 is currently in a Phase I clinical trial for solid tumors at Memorial Sloan Kettering Cancer Center. Here, we assessed intravesical delivery of second-generation r…